Recall record at a glance
| Official record | F-1292-2013 |
|---|---|
| Category | Food Recalls |
| Classification | Class II |
| FDA record status | Terminated |
| Recalling firm | Producers Peanut Company Inc. |
| Report date | Apr 10, 2013 |
| Recall initiation date | Mar 14, 2013 |
| Quantity | 506 cs= 5760 lbs (crunchy) |
| Location | Suffolk, VA, United States |
Official product description
Happy Kids Crunchy Peanut butter, packed in 8 oz, 12 oz, 28 oz, packed 12 jars/cs and 40 oz jars, packed 6 jars/cs; jars are labeled in part ***Manufactured by Producers Peanut Co., Inc. 337 Moore Ave., Suffolk, VA 23434***
Why the product was recalled
Peanut butter may contain aflatoxins above allowable levels.
Distribution information
Distributed in New York, Virginia, Illinois, Maryland, and exported to Barbados.
How to read the classification
FDA Class II indicates a situation in which use of or exposure to the product may cause temporary or medically reversible adverse health consequences, or where the probability of serious consequences is remote. The classification shown here comes from the FDA record.
Additional record details
Recall type: Voluntary: Firm initiated. Initial notification: Telephone.
What to do next
If you believe you have the recalled product, use the recall number and firm information above to confirm the official notice and follow the instructions issued by the FDA, recalling firm, retailer or product manufacturer. For drugs and medical devices, decisions about treatment or medical care should be discussed with a qualified health professional.
About this record
Recall Lookup USA preserves the most complete source information successfully retrieved. We do not create missing facts or infer affected lots or VINs. The official record may still change, so use the identifier above when verifying current instructions.
FDA source limitation: openFDA enforcement reports are a reference dataset, not a live public-alert or recall-lifecycle service. FDA notes that enforcement-report status may not be updated after classification. Confirm current actions with the FDA, recalling firm or appropriate healthcare professional when relevant.